nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CASP3—Alzheimer's disease	0.348	0.476	CbGaD
Minocycline—IL1B—Alzheimer's disease	0.221	0.303	CbGaD
Minocycline—VEGFA—Alzheimer's disease	0.161	0.221	CbGaD
Minocycline—SLC22A8—choroid plexus—Alzheimer's disease	0.0105	0.133	CbGeAlD
Minocycline—CYCS—blood vessel—Alzheimer's disease	0.005	0.0633	CbGeAlD
Minocycline—CASP3—blood vessel—Alzheimer's disease	0.00428	0.0542	CbGeAlD
Minocycline—IL1B—blood vessel—Alzheimer's disease	0.00342	0.0433	CbGeAlD
Minocycline—CYCS—embryo—Alzheimer's disease	0.00298	0.0377	CbGeAlD
Minocycline—MMP9—blood vessel—Alzheimer's disease	0.00285	0.0361	CbGeAlD
Minocycline—CASP1—forebrain—Alzheimer's disease	0.00274	0.0347	CbGeAlD
Minocycline—CYCS—forebrain—Alzheimer's disease	0.00264	0.0334	CbGeAlD
Minocycline—Tetracycline—PRNP—Alzheimer's disease	0.00258	1	CrCbGaD
Minocycline—CASP3—embryo—Alzheimer's disease	0.00255	0.0323	CbGeAlD
Minocycline—CYCS—telencephalon—Alzheimer's disease	0.00242	0.0307	CbGeAlD
Minocycline—CASP3—forebrain—Alzheimer's disease	0.00226	0.0286	CbGeAlD
Minocycline—CASP3—telencephalon—Alzheimer's disease	0.00208	0.0263	CbGeAlD
Minocycline—IL1B—embryo—Alzheimer's disease	0.00204	0.0258	CbGeAlD
Minocycline—IL1B—forebrain—Alzheimer's disease	0.0018	0.0228	CbGeAlD
Minocycline—MMP9—embryo—Alzheimer's disease	0.0017	0.0215	CbGeAlD
Minocycline—IL1B—telencephalon—Alzheimer's disease	0.00166	0.021	CbGeAlD
Minocycline—VEGFA—telencephalon—Alzheimer's disease	0.00163	0.0207	CbGeAlD
Minocycline—CASP1—nervous system—Alzheimer's disease	0.00149	0.0188	CbGeAlD
Minocycline—CASP1—central nervous system—Alzheimer's disease	0.00143	0.0181	CbGeAlD
Minocycline—CYCS—nervous system—Alzheimer's disease	0.00143	0.0181	CbGeAlD
Minocycline—CASP1—cerebellum—Alzheimer's disease	0.0014	0.0177	CbGeAlD
Minocycline—CYCS—central nervous system—Alzheimer's disease	0.00138	0.0174	CbGeAlD
Minocycline—CYCS—cerebellum—Alzheimer's disease	0.00135	0.0171	CbGeAlD
Minocycline—CASP3—nervous system—Alzheimer's disease	0.00123	0.0155	CbGeAlD
Minocycline—CASP3—central nervous system—Alzheimer's disease	0.00118	0.0149	CbGeAlD
Minocycline—CASP3—cerebellum—Alzheimer's disease	0.00115	0.0146	CbGeAlD
Minocycline—CASP1—brain—Alzheimer's disease	0.00114	0.0144	CbGeAlD
Minocycline—CYCS—brain—Alzheimer's disease	0.00109	0.0138	CbGeAlD
Minocycline—IL1B—nervous system—Alzheimer's disease	0.000979	0.0124	CbGeAlD
Minocycline—IL1B—central nervous system—Alzheimer's disease	0.000943	0.0119	CbGeAlD
Minocycline—CASP3—brain—Alzheimer's disease	0.000937	0.0119	CbGeAlD
Minocycline—VEGFA—cerebellum—Alzheimer's disease	0.000906	0.0115	CbGeAlD
Minocycline—MMP9—nervous system—Alzheimer's disease	0.000816	0.0103	CbGeAlD
Minocycline—MMP9—central nervous system—Alzheimer's disease	0.000786	0.00995	CbGeAlD
Minocycline—IL1B—brain—Alzheimer's disease	0.000748	0.00948	CbGeAlD
Minocycline—VEGFA—brain—Alzheimer's disease	0.000736	0.00932	CbGeAlD
Minocycline—ALOX5—nervous system—Alzheimer's disease	0.000645	0.00817	CbGeAlD
Minocycline—MMP9—brain—Alzheimer's disease	0.000624	0.0079	CbGeAlD
Minocycline—ALOX5—central nervous system—Alzheimer's disease	0.000621	0.00787	CbGeAlD
Minocycline—ALOX5—cerebellum—Alzheimer's disease	0.000607	0.00769	CbGeAlD
Minocycline—SLC22A7—brain—Alzheimer's disease	0.000577	0.00731	CbGeAlD
Minocycline—SLC22A6—brain—Alzheimer's disease	0.000557	0.00705	CbGeAlD
Minocycline—ALOX5—brain—Alzheimer's disease	0.000493	0.00624	CbGeAlD
Minocycline—SLC22A8—nervous system—Alzheimer's disease	0.000436	0.00553	CbGeAlD
Minocycline—SLC22A8—central nervous system—Alzheimer's disease	0.00042	0.00532	CbGeAlD
Minocycline—SLC22A8—brain—Alzheimer's disease	0.000334	0.00422	CbGeAlD
Minocycline—CYCS—Metabolism—PPARGC1A—Alzheimer's disease	1.62e-05	8.59e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—GSK3B—Alzheimer's disease	1.62e-05	8.58e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—HMOX1—Alzheimer's disease	1.61e-05	8.55e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—NOTCH1—Alzheimer's disease	1.6e-05	8.52e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—CREB1—Alzheimer's disease	1.6e-05	8.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.6e-05	8.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	1.59e-05	8.43e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—S100B—Alzheimer's disease	1.58e-05	8.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PSENEN—Alzheimer's disease	1.57e-05	8.35e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CRH—Alzheimer's disease	1.57e-05	8.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CDK5—Alzheimer's disease	1.56e-05	8.3e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APH1A—Alzheimer's disease	1.55e-05	8.24e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARG—Alzheimer's disease	1.51e-05	8.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NCSTN—Alzheimer's disease	1.51e-05	8.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—LEP—Alzheimer's disease	1.51e-05	8.01e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—GSK3B—Alzheimer's disease	1.51e-05	7.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR6—Alzheimer's disease	1.5e-05	7.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PLAU—Alzheimer's disease	1.5e-05	7.97e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CREB1—Alzheimer's disease	1.49e-05	7.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.49e-05	7.93e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NPS—Alzheimer's disease	1.49e-05	7.91e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.49e-05	7.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CALM1—Alzheimer's disease	1.49e-05	7.89e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—INS—Alzheimer's disease	1.49e-05	7.89e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PPP3CA—Alzheimer's disease	1.48e-05	7.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LRP1—Alzheimer's disease	1.47e-05	7.82e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—LPL—Alzheimer's disease	1.47e-05	7.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CAV1—Alzheimer's disease	1.47e-05	7.79e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PTK2B—Alzheimer's disease	1.46e-05	7.75e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—MAPK8—Alzheimer's disease	1.46e-05	7.73e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ACHE—Alzheimer's disease	1.45e-05	7.71e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—Alzheimer's disease	1.45e-05	7.69e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GAL—Alzheimer's disease	1.44e-05	7.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GFAP—Alzheimer's disease	1.44e-05	7.64e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INPP5D—Alzheimer's disease	1.43e-05	7.62e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1A—Alzheimer's disease	1.43e-05	7.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.42e-05	7.55e-05	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—Alzheimer's disease	1.42e-05	7.55e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK2—Alzheimer's disease	1.42e-05	7.54e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SST—Alzheimer's disease	1.42e-05	7.54e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GAB2—Alzheimer's disease	1.42e-05	7.54e-05	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.42e-05	7.52e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3A—Alzheimer's disease	1.41e-05	7.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—F2—Alzheimer's disease	1.4e-05	7.41e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NOTCH1—Alzheimer's disease	1.39e-05	7.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APP—Alzheimer's disease	1.38e-05	7.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—Alzheimer's disease	1.38e-05	7.32e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MEF2C—Alzheimer's disease	1.38e-05	7.32e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AGER—Alzheimer's disease	1.37e-05	7.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSENEN—Alzheimer's disease	1.37e-05	7.25e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ENO1—Alzheimer's disease	1.36e-05	7.22e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS1—Alzheimer's disease	1.36e-05	7.22e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.36e-05	7.22e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRKCG—Alzheimer's disease	1.35e-05	7.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APH1A—Alzheimer's disease	1.35e-05	7.15e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—BCL2—Alzheimer's disease	1.35e-05	7.14e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	1.34e-05	7.12e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—AKT1—Alzheimer's disease	1.34e-05	7.09e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2D6—Alzheimer's disease	1.33e-05	7.08e-05	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—Alzheimer's disease	1.33e-05	7.08e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MTHFR—Alzheimer's disease	1.33e-05	7.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.32e-05	6.99e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—VEGFA—Alzheimer's disease	1.32e-05	6.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARG—Alzheimer's disease	1.31e-05	6.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCSTN—Alzheimer's disease	1.31e-05	6.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—GSK3B—Alzheimer's disease	1.31e-05	6.94e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PLCB1—Alzheimer's disease	1.31e-05	6.94e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CREB1—Alzheimer's disease	1.3e-05	6.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—INS—Alzheimer's disease	1.29e-05	6.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LRP1—Alzheimer's disease	1.28e-05	6.79e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—A2M—Alzheimer's disease	1.27e-05	6.73e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—BCHE—Alzheimer's disease	1.26e-05	6.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GAL—Alzheimer's disease	1.25e-05	6.63e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GFAP—Alzheimer's disease	1.25e-05	6.63e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CALM1—Alzheimer's disease	1.24e-05	6.58e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—APOE—Alzheimer's disease	1.23e-05	6.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PSEN2—Alzheimer's disease	1.23e-05	6.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—IGF1—Alzheimer's disease	1.22e-05	6.5e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CAV1—Alzheimer's disease	1.22e-05	6.49e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGFR—Alzheimer's disease	1.22e-05	6.47e-05	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—Alzheimer's disease	1.2e-05	6.35e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PLCB1—Alzheimer's disease	1.19e-05	6.33e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADAM10—Alzheimer's disease	1.19e-05	6.32e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—Alzheimer's disease	1.19e-05	6.31e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.17e-05	6.21e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CALM1—Alzheimer's disease	1.17e-05	6.21e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ABCA1—Alzheimer's disease	1.16e-05	6.14e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.14e-05	6.03e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NPY—Alzheimer's disease	1.13e-05	6e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—S100B—Alzheimer's disease	1.13e-05	5.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IAPP—Alzheimer's disease	1.12e-05	5.96e-05	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—AKT1—Alzheimer's disease	1.12e-05	5.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.11e-05	5.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS3—Alzheimer's disease	1.11e-05	5.89e-05	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AKT1—Alzheimer's disease	1.1e-05	5.86e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—A2M—Alzheimer's disease	1.1e-05	5.85e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—MAPK8—Alzheimer's disease	1.09e-05	5.79e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CRH—Alzheimer's disease	1.09e-05	5.79e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARG—Alzheimer's disease	1.08e-05	5.71e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF2—Alzheimer's disease	1.07e-05	5.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PSEN2—Alzheimer's disease	1.07e-05	5.66e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—INS—Alzheimer's disease	1.05e-05	5.6e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1R—Alzheimer's disease	1.04e-05	5.5e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NPS—Alzheimer's disease	1.03e-05	5.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PPP3CA—Alzheimer's disease	1.03e-05	5.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—Alzheimer's disease	1.02e-05	5.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTK2B—Alzheimer's disease	1.01e-05	5.38e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—GSK3B—Alzheimer's disease	1.01e-05	5.36e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—CREB1—Alzheimer's disease	1e-05	5.32e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARGC1A—Alzheimer's disease	9.97e-06	5.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LPL—Alzheimer's disease	9.94e-06	5.28e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMOX1—Alzheimer's disease	9.92e-06	5.27e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	9.89e-06	5.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK2—Alzheimer's disease	9.86e-06	5.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GAB2—Alzheimer's disease	9.86e-06	5.24e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SST—Alzheimer's disease	9.86e-06	5.24e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MEF2C—Alzheimer's disease	9.85e-06	5.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPY—Alzheimer's disease	9.81e-06	5.21e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3A—Alzheimer's disease	9.78e-06	5.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IAPP—Alzheimer's disease	9.75e-06	5.18e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCG—Alzheimer's disease	9.66e-06	5.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APP—Alzheimer's disease	9.61e-06	5.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CRH—Alzheimer's disease	9.47e-06	5.03e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NGF—Alzheimer's disease	9.41e-06	5e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—VEGFA—Alzheimer's disease	9.38e-06	4.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—Alzheimer's disease	9.3e-06	4.94e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—Alzheimer's disease	9.25e-06	4.91e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR5—Alzheimer's disease	9.16e-06	4.86e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—Alzheimer's disease	9.1e-06	4.83e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LPL—Alzheimer's disease	9.08e-06	4.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLCB1—Alzheimer's disease	9.07e-06	4.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPS—Alzheimer's disease	8.98e-06	4.76e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—Alzheimer's disease	8.96e-06	4.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PPP3CA—Alzheimer's disease	8.93e-06	4.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTK2B—Alzheimer's disease	8.8e-06	4.67e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—Alzheimer's disease	8.61e-06	4.57e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SST—Alzheimer's disease	8.56e-06	4.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GAB2—Alzheimer's disease	8.56e-06	4.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK2—Alzheimer's disease	8.56e-06	4.55e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3A—Alzheimer's disease	8.49e-06	4.51e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGFR—Alzheimer's disease	8.46e-06	4.49e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—Alzheimer's disease	8.46e-06	4.49e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—Alzheimer's disease	8.41e-06	4.47e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CALM1—Alzheimer's disease	8.36e-06	4.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APP—Alzheimer's disease	8.34e-06	4.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—Alzheimer's disease	8.33e-06	4.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—Alzheimer's disease	8.33e-06	4.42e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADAM10—Alzheimer's disease	8.27e-06	4.39e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CAV1—Alzheimer's disease	8.25e-06	4.38e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—Alzheimer's disease	8.17e-06	4.34e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—Alzheimer's disease	8.04e-06	4.27e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—Alzheimer's disease	7.95e-06	4.22e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—Alzheimer's disease	7.9e-06	4.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLCB1—Alzheimer's disease	7.87e-06	4.18e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—Alzheimer's disease	7.86e-06	4.17e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—S100B—Alzheimer's disease	7.82e-06	4.15e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOTCH1—Alzheimer's disease	7.69e-06	4.08e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CALM1—Alzheimer's disease	7.63e-06	4.05e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—Alzheimer's disease	7.61e-06	4.04e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAV1—Alzheimer's disease	7.54e-06	4e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—Alzheimer's disease	7.48e-06	3.97e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF2—Alzheimer's disease	7.44e-06	3.95e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGFR—Alzheimer's disease	7.35e-06	3.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—Alzheimer's disease	7.33e-06	3.89e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—GSK3B—Alzheimer's disease	7.21e-06	3.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1R—Alzheimer's disease	7.2e-06	3.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADAM10—Alzheimer's disease	7.18e-06	3.81e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CREB1—Alzheimer's disease	7.16e-06	3.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—Alzheimer's disease	7.12e-06	3.78e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—Alzheimer's disease	7e-06	3.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—Alzheimer's disease	6.98e-06	3.71e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—Alzheimer's disease	6.96e-06	3.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LPL—Alzheimer's disease	6.9e-06	3.66e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—Alzheimer's disease	6.88e-06	3.65e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MEF2C—Alzheimer's disease	6.84e-06	3.63e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK8—Alzheimer's disease	6.82e-06	3.62e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—S100B—Alzheimer's disease	6.78e-06	3.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCG—Alzheimer's disease	6.71e-06	3.56e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—Alzheimer's disease	6.63e-06	3.52e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NGF—Alzheimer's disease	6.53e-06	3.47e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—Alzheimer's disease	6.5e-06	3.45e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—Alzheimer's disease	6.49e-06	3.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF2—Alzheimer's disease	6.46e-06	3.43e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—Alzheimer's disease	6.43e-06	3.41e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR5—Alzheimer's disease	6.36e-06	3.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1R—Alzheimer's disease	6.25e-06	3.32e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—Alzheimer's disease	6.24e-06	3.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—Alzheimer's disease	6.22e-06	3.3e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—Alzheimer's disease	6.04e-06	3.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LPL—Alzheimer's disease	5.99e-06	3.18e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—Alzheimer's disease	5.99e-06	3.18e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MEF2C—Alzheimer's disease	5.93e-06	3.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCG—Alzheimer's disease	5.82e-06	3.09e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CALM1—Alzheimer's disease	5.8e-06	3.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—Alzheimer's disease	5.78e-06	3.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—Alzheimer's disease	5.78e-06	3.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CAV1—Alzheimer's disease	5.73e-06	3.04e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—Alzheimer's disease	5.7e-06	3.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NGF—Alzheimer's disease	5.67e-06	3.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—Alzheimer's disease	5.63e-06	2.99e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—Alzheimer's disease	5.52e-06	2.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR5—Alzheimer's disease	5.52e-06	2.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—Alzheimer's disease	5.45e-06	2.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—Alzheimer's disease	5.4e-06	2.87e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOTCH1—Alzheimer's disease	5.34e-06	2.83e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—Alzheimer's disease	5.21e-06	2.77e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—Alzheimer's disease	5.2e-06	2.76e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—Alzheimer's disease	5.1e-06	2.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CALM1—Alzheimer's disease	5.04e-06	2.67e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—Alzheimer's disease	5.02e-06	2.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—Alzheimer's disease	5.02e-06	2.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GSK3B—Alzheimer's disease	5.01e-06	2.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CAV1—Alzheimer's disease	4.97e-06	2.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CREB1—Alzheimer's disease	4.97e-06	2.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—Alzheimer's disease	4.94e-06	2.62e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK8—Alzheimer's disease	4.87e-06	2.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—Alzheimer's disease	4.86e-06	2.58e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—Alzheimer's disease	4.79e-06	2.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—Alzheimer's disease	4.78e-06	2.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—Alzheimer's disease	4.73e-06	2.51e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOTCH1—Alzheimer's disease	4.63e-06	2.46e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VEGFA—Alzheimer's disease	4.5e-06	2.39e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—Alzheimer's disease	4.35e-06	2.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GSK3B—Alzheimer's disease	4.35e-06	2.31e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—Alzheimer's disease	4.33e-06	2.3e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CREB1—Alzheimer's disease	4.31e-06	2.29e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—Alzheimer's disease	4.29e-06	2.28e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—Alzheimer's disease	4.25e-06	2.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—Alzheimer's disease	4.22e-06	2.24e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—Alzheimer's disease	4.15e-06	2.2e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—Alzheimer's disease	4.13e-06	2.19e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—Alzheimer's disease	4.02e-06	2.13e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—Alzheimer's disease	3.76e-06	2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CASP3—Alzheimer's disease	3.68e-06	1.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—Alzheimer's disease	3.4e-06	1.8e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK8—Alzheimer's disease	3.38e-06	1.79e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CASP3—Alzheimer's disease	3.19e-06	1.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VEGFA—Alzheimer's disease	3.12e-06	1.66e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—Alzheimer's disease	3.11e-06	1.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK8—Alzheimer's disease	2.93e-06	1.56e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—Alzheimer's disease	2.87e-06	1.52e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—Alzheimer's disease	2.86e-06	1.52e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—Alzheimer's disease	2.62e-06	1.39e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—Alzheimer's disease	2.49e-06	1.32e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—Alzheimer's disease	2.36e-06	1.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—Alzheimer's disease	2.16e-06	1.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—Alzheimer's disease	2.05e-06	1.09e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—Alzheimer's disease	1.99e-06	1.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—Alzheimer's disease	1.87e-06	9.95e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—Alzheimer's disease	1.73e-06	9.18e-06	CbGpPWpGaD
